HIV Prevention

2. Questions to the Minister for Health and Social Services – in the Senedd on 9 January 2019.

Alert me about debates like this

Photo of Vikki Howells Vikki Howells Labour

(Translated)

6. Will the Welsh Government provide an update on the action it is taking in relation to HIV prevention? OAQ53146

Photo of Vaughan Gething Vaughan Gething Labour 3:05, 9 January 2019

Thank you for the question. A number of projects are under way to improve access to testing, including the provision of self-sampling HIV tests and a pilot for online testing. Pre-exposure prophylaxis is providing protection for those with lifestyle risks. These measures, supported by effective medical care, mean we are continually reducing the risk of HIV infection.

Photo of Vikki Howells Vikki Howells Labour 3:06, 9 January 2019

Thank you, Minister. I've been closely following the encouraging response to the introduction of PrEP last July. I'm really impressed by the large numbers already benefiting from this preventative treatment. The introduction of a national approach to PrEP and HIV prevention that is being taken here in Wales by the Welsh Labour Government shows a clear commitment to these issues. What plans are in place to build on any early findings? Would you be able to provide an update on further results when these become available in due course?

Photo of Vaughan Gething Vaughan Gething Labour

Yes, I'm very pleased and proud of the national approach that we've chosen to take here in Wales—a genuinely national approach based on clinical need being the criteria for access to PrEP. That's in contrast to the approach taken in both Northern Ireland and England, where there isn't a national approach and, of course, the Terrence Higgins Trust and others are fundraising to be able to make the funds available for people to actually be able to use PrEP. That isn't a challenge we have here. 

We now have, from the end of September, 697 people in Wales who've been prescribed PrEP, and 386 are currently taking the preventative treatment. There have been no new cases of HIV within that group of people, and that is a real success story for all of us.

We do, though, recognise that about one in four people who are potentially eligible for PrEP don't come back for follow-up and don't actually take it up. So, part of our challenge, in research that is ongoing, is both to properly understand the impact of providing PrEP and to make sure that we continue to see that reduction in HIV, but also to try to understand why some people don't access PrEP when it is potentially available.

There is a range of research, including funding that we provided to Cardiff University—£400,000 of funding—to carry out research into the behaviours of those who choose to take PrEP, because we do recognise that there is a high incidence of sexually transmitted infections being acquired by people who are taking PrEP, so it's actually getting to the right sort of cohort of people.

I will, of course, though, in terms of your final point, happily update this place when we do have the results of either further incidents of the numbers of use, but, in particular, the research trials that we are already supporting.